Thrombolytic Agents

Thrombolytic agents such as streptokinase, urokinase, and tissue plasminogen activator (T-PA), are used in selected cases of acute myocardial infarction, thromboembolic venous disease, peripheral arterial occlusive disease, and other conditions. Streptokinase is derived from group C strains of B-hemolytic streptococcal material. It is antigenic in humans, and because most humans have been exposed to streptococcal infections, streptokinase antibodies are present in most patients; therefore, when streptokinase is infused, enough potential activator must be given to neutralize the circulating antibody before a lytic state can be achieved. Urokinase is an enzyme initially isolated from human urine and later from tissue...

Subscribe or sign in to view the full article.

articles:   
Note:  The following article synopsis was NOT provided by the AHA. It was created by Find-A-Code/innoviHealth.

Article Overview

This article discusses thrombolytic agents and the general clinical situations in which they are used, along with coding-related guidance for procedures performed in connection with thrombolytic therapy. It is aimed at coders, coding educators, and revenue cycle professionals who need to understand how the topic is addressed in the clinical coding literature. The article also references prior Coding Clinic discussions and an update to earlier published information.

Why This Topic Matters

Thrombolytic therapy can be associated with multiple procedure types and care settings, so understanding the scope of the guidance helps readers identify when the article is relevant. It also helps align coding reference work with historical updates and referenced coding literature.

Article Sections

  1. Overview of thrombolytic agents

    Introduces the drug class and summarizes the clinical settings in which thrombolytic therapy is used. Provides general background on the agents discussed in the article.

  2. Administration and related procedures

    Describes the broad types of procedures and interventions associated with thrombolytic therapy. Includes discussion of vascular and catheter-based procedure contexts and related coding references.

  3. Coding note and later update

    Presents a dated coding note and mentions a later update to earlier published guidance. Serves as a historical coding reference rather than a clinical discussion.

What You Will Learn

  • The general clinical uses of thrombolytic therapy
  • The kinds of procedures commonly discussed alongside thrombolytic treatment
  • How the article frames historical coding guidance and later updates
  • Which coding references and time periods the article cites

Who Should Read This

  • Medical coders
  • Coding auditors
  • Coding educators
  • Revenue cycle staff
  • Health information management professionals

Codes Discussed

  • ICD-9-CM: 99.10
  • ICD-9-CM: 99.20
  • ICD-9-CM: 36.02
  • ICD-9-CM: 36.04
  • ICD-9-CM: 88.41
  • ICD-9-CM: 99.29
  • ICD-9-CM: 39.50
  • ICD-9-CM: 38.91
  • ICD-9-CM: 39.49

Subscribe or sign in to view the full article.

articles:   
  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.

Aimee- AI -powered coding assistant - Try it now for Free Would you like Aimee - AI
to help you with this?